Before the Oxford-AstraZeneca vaccine could have been ap­proved by the World Health Organization (WHO), clinical trials were necessary to test the efficacy of the drug in inocu­lating people against the COVID-19 virus. To this end, officials in three nations agreed to conduct the trials – the United Kingdom, South Africa and Brazil – and over…